Sign up for your FREE personalized newsletter featuring insights, trends, and news for America's Active Baby Boomers

Newsletter
New

Why Hawkins Stock Surged 5% Today

Card image cap

Defying today's market downturn, water treatment company Hawkins (NASDAQ: HWKN) saw its shares move higher on Monday after announcing it has acquired all the assets of rival water treatment chemicals and equipment company Amerochem.

As of 12:25 p.m. ET, Hawkins stock is up 5.6%.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks »

Hawkins swoops in

"Amerochem has built an incredible business over the past 30 plus years," explained Hawkins CEO Patrick Hawkins, "and has great relationships with its customers, suppliers and employees" that Hawkins intends to maintain and expand.

What Hawkins didn't say, however, is how much it paid for Amerochem's assets. Nor did the company give investors much information with which to determine if this deal is a good or bad one for Hawkins. Hawkins' press release noted that its "footprint" will expand with the acquisition of Amerochem's market, which is primarily in North Carolina.

The company did not give any indication of the size of the market in terms of either revenue or profitability.

Is Hawkins stock a buy?

Investors, therefore, seem to be taking it on faith that Hawkins made a good deal here. That's not entirely without basis. Hawkins noted that this is only its second acquisition in North Carolina, which suggests it's being careful about what it buys, and how much it pays. But investors are still flying pretty blind here as regards specifics.

Still, were I considering an investment in Hawkins stock, I'd be cautious. The stock trades for more than 27 times earnings, but analysts who follow Hawkins don't expect the company to grow earnings much faster than 7% annually over the next five years. Free cash flow at the company is strong at $80 million generated over the last 12 months, in line with reported earnings. And Hawkins' debt load is modest, less than $120 million net of cash, on a $2.2 billion market capitalization.

All things considered, I'd call this a good business but an overpriced stock. Lacking more data on the Amerochem acquisition's specifics, I see no reason to change this assessment.

Should you invest $1,000 in Hawkins right now?

Before you buy stock in Hawkins, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hawkins wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $735,852!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.

Learn more »

*Stock Advisor returns as of February 3, 2025

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.


Recent